The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety, PD-L1 expression, and clinical activity of avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with advanced gastric or gastroesophageal junction cancer.
 
Hyun Cheol Chung
No Relationships to Disclose
 
Hendrik-Tobias Arkenau
No Relationships to Disclose
 
Lucjan Wyrwicz
No Relationships to Disclose
 
Do-Youn Oh
No Relationships to Disclose
 
Keun-Wook Lee
No Relationships to Disclose
 
Jeffrey R. Infante
No Relationships to Disclose
 
Kevin M. Chin
No Relationships to Disclose
 
Anja von Heydebreck
No Relationships to Disclose
 
Yoon-Koo Kang
Consulting or Advisory Role - Lilly/ImClone; Novartis; Ono Pharmaceutical; Roche/Genentech; Taiho Pharmaceutical
Research Funding - Bayer; Novartis; Roche/Genentech
 
Howard Safran
No Relationships to Disclose